$560.73
+9.91 (+1.80%)
At Close: Jun 03, 2026
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors
07:00am, Thursday, 10'th Jul 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Joseph L. (Jay) Hooley to the Company's Board
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 07'th Jul 2025
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Idexx Laboratories price target raised by $30 at Stifel, here's why
06:57am, Wednesday, 02'nd Jul 2025
04 Aug
IDEXX Laboratories to Release 2025 Second Quarter Financial Results
01:00pm, Tuesday, 24'th Jun 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 second quarter financial results for Mon
The Catalyst ® Cortisol Test provides veterinarians with real-time critical insights when evaluating dogs for Addison's disease and Cushing's syndrome WESTBROOK, Maine , June 5, 2025 /PRNewswire/ --
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
09:11am, Thursday, 15'th May 2025
Five high-flying medical instrument stocks are: DXCM, IDXX, NPCE, CLPT, FMS.
IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits
02:35pm, Wednesday, 14'th May 2025
IDEXX Laboratories, Inc. delivered strong Q1 FY25 results with 4.7% organic revenue and 7% adjusted EPS growth, despite weak US clinical visits. I see catalysts ahead: potential U.S. tax cuts, normali
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
10:41am, Wednesday, 14'th May 2025
Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
02:30pm, Tuesday, 13'th May 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financ
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
10:36am, Thursday, 01'st May 2025
Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street es
IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript
10:35am, Thursday, 01'st May 2025
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Andrew Emerson - EVP, CFO and Treasurer Jay Mazelsky - President and CEO Conference
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates
08:40am, Thursday, 01'st May 2025
Idexx Laboratories (IDXX) came out with quarterly earnings of $2.96 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.81 per share a year ago.
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics
08:21am, Thursday, 01'st May 2025
Animal diagnostics maker IDEXX Laboratories on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it benefited from customer retention and increase
IDEXX Laboratories Announces First Quarter Results
06:30am, Thursday, 01'st May 2025
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. “IDEXX drove solid execution in the f
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
10:35am, Wednesday, 30'th Apr 2025
The first-quarter 2025 earnings season is underway, with a number of top MedTech companies already releasing their numbers. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
Sign In
Buy IDXX